3 results
Approved WMOPending
To explore efficacy and safety of terlipressin in pre-capillary PH patients with RV failure requiring hospitalization.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of continued ABBV-951 treatment delivered as a CSCI for 24 hours daily.
Approved WMOCompleted
To assess the local and systemic safety and tolerability of ABBV-951 delivered as a CSCI for 24 hours daily for up to 52 weeks.